Monon Bioventures awarded nearly $400,000 from the National Cancer Institute

Monon Bioventures will be partnering with fellow ICBI company, Genezen, and the Purdue University College of Pharmacy to study the feasibility of manufacturing a glioblastoma therapeutic using human immune natural killer (NK) cells, a therapeutic created at the Purdue University College of Pharmacy. Read more Ledger Live: Stay connected to the crypto world with real-time … Read more

HHS Secretary Becerra Establishes ARPA-H within NIH, Names Adam H. Russell, D.Phil. Acting Deputy Director

“We are ecstatic that Dr. Adam Russell has accepted the challenge to help launch ARPA-H, President Biden’s bold, new endeavor to support ambitious and potentially transformational health research in this country,” said Secretary Becerra. “ARPA-H will have a singular purpose: to drive breakthroughs in health, including the prevention, detection and treatment of diseases such as cancer, Alzheimer’s … Read more

White House releases guidance for science agencies

Recently there have been some high-profile cases in the news and most recently the Dept. of Justice secured a guilty verdict against prominent Harvard chemistry professor Charles Lieber with regards to disclosures of federally funded research dollars in academia. The White House released guidance for science agencies to use as they implement National Security Presidential Memorandum … Read more

Genezen Labs Secures Funding to Establish Fishers Presence

A Fishers-based cell and gene therapy company has received a capital infusion it says will fuel growth in central Indiana. Genezen Laboratories Inc., which manufactures viral vectors used to treat rare diseases and cellular therapies to treat cancer, says the growth equity investment from Massachusetts-based Ampersand Capital Partners will be used to complete construction on … Read more

Indiana Center for Biomedical Innovation interns wrap up summer session

ICBI summer interns

Interns and mentors are finishing their summer research with the Indiana Center for Biomedical Innovation (ICBI) this month. The program supports Indiana Clinical and Translational Sciences Institute’s goal of teaching undergraduate students while giving them hands-on training in translational research and entrepreneurship. Read more…

ICBI company, Scioto Biosciences and Abigail Wexner Research Institute at Nationwide Children’s Hospital Receive a $2.3 Million Dollar Phase II SBIR Grant to Develop Novel Therapy

scioto logo

Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced that they are a recipient of a Phase II SBIR grant from the National Institutes of Health (NIH) for $2.3 million. The Phase II award is to continue to support the research with Scioto’s collaborator, the Abigail … Read more

Dr. Timothy Hsiao, Program Director at the National Center for Advancing Translational Sciences (NCATS) visited the CTSI incubator, Indiana Center for Biomedical Innovation (ICBI)

The federal government provides various supports for health ventures to strengthen the country’s public health and innovation-driven economy. Dr. H. Timothy Hsiao, the Program Director at the National Center for Advancing Translational Sciences, discussed NIH’s relevant sources of funding and technical assistance, including but not limited to the: Small Business Technology Transfer (R41/R42), Small Business … Read more

IU Philanthropic Venture Fund invests in ICBI companies


The Indiana Philanthropic Venture Fund (IU PhV) is on the doorstep of its one-year anniversary and, although not limited to the life sciences, it has funneled $1.6 million into the sector’s early-stage Indiana-based companies. Its visionaries designed the evergreen fund to be a “perpetual resource” and an answer for Indiana University alums who want to … Read more